Work

Muscle invasive bladder cancer (MIBC) demonstrates neoadjuvant cisplatin-based chemotherapy (NAC) related changes in molecular subtype and immune infiltration.

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.7_suppl.443

Authors: Samuel Aaron Funt, Alexander Solovyov, Bishoy Morris Faltas, Gopa Iyer, Mariel Elena Boyd, Catharine Kline Cipolla, Ashley Marie Regazzi, Min Yuen Teo, Chung-Han Lee, Hikmat Al-Ahmadie, Jonathan E. Rosenberg, Benjamin Greenbaum, Dean F. Bajorin

Institutions: Memorial Sloan Kettering Cancer Center, Icahn School of Medicine at Mount Sinai, Weill Cornell Medicine

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2921319894

Cites:

Cited by:

Related to: 10